AI-Driven Drug Discovery: Hype or Healthcare Breakthrough?

Published

By TaiwanPlus

Clinical trials, biotech research and drug discovery could all be accelerated by AI, industry experts say. But what does that mean for achieving the long-awaited medical breakthroughs people care about most, such as cancer treatments and therapies for rare diseases? Our guests explain how AI-driven medicines are moving closer to patients. Featuring: Emily Fang (InFocus Therapeutics) and Servina Liu (Taiwan Biomedical Innovation Association) Host: Divya Gopalan